Oncimmune Holdings PLC
LSE:ONC

Watchlist Manager
Oncimmune Holdings PLC Logo
Oncimmune Holdings PLC
LSE:ONC
Watchlist
Price: 1.14 GBX Market Closed
Market Cap: 1.3m GBX

Wall Street
Price Targets

ONC Price Targets Summary
Oncimmune Holdings PLC

There are no price targets for ONC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Oncimmune Holdings PLC Competitors:
Price Targets
IKT
Inhibikase Therapeutics Inc
244% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
26% Upside
2171
CARsgen Therapeutics Holdings Ltd
52% Upside
AZT
Arcticzymes Technologies ASA
54% Upside
CGON
CG Oncology Inc
82% Upside
PRTA
Prothena Corporation PLC
114% Upside
068270
Celltrion Inc
22% Upside
DTIL
Precision BioSciences Inc
664% Upside

Revenue
Forecast

Revenue Estimate
Oncimmune Holdings PLC

For the last 1 year the compound annual growth rate for Oncimmune Holdings PLC's revenue is 138%. The projected CAGR for the next 1 year is 159%.

138%
Past Growth
159%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oncimmune Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Oncimmune Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONC's stock price target?
Not Available

ONC doesn't have any price targets made by Wall Street professionals.

What is Oncimmune Holdings PLC's Revenue forecast?
Projected CAGR
159%

For the last 1 year the compound annual growth rate for Oncimmune Holdings PLC's revenue is 138%. The projected CAGR for the next 1 year is 159%.

Back to Top